Low-Dose Naltrexone Improves post-COVID-19 Condition Symptoms

Leonardo Tamariz, Elizabeth Bast, Nancy Klimas, Ana Palacio

Clin Ther, . 23rd Jan 2024:S0149-2918(24)00003-1. https://pubmed.ncbi.nlm.nih.gov/38267326/

Abstract
Purpose: Treatments for myalgic encephalomyelitis and chronic fatigue syndrome can be adapted for post-COVID-19 condition. Our aim was to compare treatments in patients from our post-COVID-19 clinic.

New Research Aims to Unravel Both ME/CFS and Long COVID
Miriam E. Tucker
Medscape Medical News > Conference News
December 21, 2023

https://www.medscape.com/viewarticle/new-research-aims-unravel-both-me-cfs-and-long-covid-2023a1000w9b?form=fpf

A key to a ‘faulty’ lock: Why Aussie researchers are excited about naltrexone for CFS

Ausdoc.com
31 July 2023
https://www.ausdoc.com.au/news/a-key-to-a-faulty-lock-why-aussie-researchers-are-excited-about-naltrexone-for-cfs/